Skip to Main Content

Paper Details

Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program.
JCO Oncol Pract
6
2021
  • 1 - 2

Datasets